Why Do We in Academic Science Go Quiet in Rooms Where the Money Is?
University researchers need to stand up for “useless” science when funders question its purpose
I moved from Brazil to American academia, where things work differently. Back home, universities and industry mostly stay separate. Here, they work together. Companies fund labs, donors put their names on buildings, and professors are encouraged to think like entrepreneurs. I find much of this exciting. But I do worry about what happens to people like me when we sit across from those who control the money.
In those meetings, we stop speaking up as professors. Our job is to teach, question, and challenge ideas. But when the person across from us holds the funding, we just nod along. We let bold claims about what research matters go unchallenged, even though we would correct a student in the same situation.
Staying quiet comes at a price. In October, George Mason University economist Tyler Cowen interviewed Michael Kratsios, director of the White House Office of Science and Technology Policy, on the New York Times podcast Interesting Times. Cowen pointed out the temptation to fund only the most dynamic and productive areas. He also argued that maybe we should support the less productive parts that need help. Kratsios replied that federal science spending uses “a portfolio approach.”
To be fair, the plan discussed in that conversation is better than some critics claim. The White House report Science: A New Golden Age supports curiosity. It says, “Pure curiosity-driven research can also deliver immense value to society,” and gives credit to Riemann’s abstract geometry for making Einstein’s general relativity possible. The report urges agencies to keep “space for the serendipity that no thesis can anticipate” and suggests creating curiosity-driven institutes. On this principle, Kratsios and I agree.
What worries me is the method. The same report tells agencies to build portfolios “with thesis-driven conviction about where breakthroughs are most likely to emerge.” But a thesis is just a prediction. History shows that many confident predictions in science turned out to be wrong.
There are plenty of famous examples. CRISPR started in 1989 as strange repeats in a salt-marsh microbe. The laser was once called “a solution looking for a problem.” MRI, the World Wide Web, the touchscreen, and GPS all began as answers to different questions. Even mRNA vaccines came from work that was so unpopular that one of its pioneers, Katalin Karikó, was demoted. Her collaborator Drew Weissman said, “We couldn’t get funding; we couldn’t get publications; we couldn’t get people to recognize RNA as something interesting.”
A lesser-known example shows this even better. In the 1970s, John O’Sullivan and his team at Australia’s national science agency used radio-astronomy math to search for faint signals from exploding black holes. They never found those signals. But their technique for finding weak signals in noise became the basis for wireless networking, earning the agency about 430 million Australian dollars. No one funding black-hole research expected to get Wi-Fi.
In my own field, there is proof sitting in museum freezers. In 1993, a mysterious and often deadly lung disease appeared in the Four Corners region of the Southwest. It turned out to be a new hantavirus carried by deer mice. Was this virus new? Biologists at the University of New Mexico checked mouse tissues that museums had stored since 1979, long before anyone worried about them. About 13 percent of the mice had antibodies, and the frozen tissues contained the virus’s genetic material. The virus had been there the whole time.
The example above supports an old idea that has lasted because people keep fighting for it. Epictetus (55 to 135 CE), a Greek Stoic philosopher, began his handbook with a line that fits research funding: “Some things are in our control and others not.” We cannot control where a discovery leads. But we can choose to let curiosity go far enough to find out. More than 2,000 years later, Abraham Flexner tried to keep this idea alive in 1939, in “The Usefulness of Useless Knowledge.” So this argument is not new. What is new is where the pressure comes from. It is in the room with the money, and that is where we fall silent.
Why does this pressure continue when history is so clear? Part of the reason is how our minds work. In 1975, Baruch Fischhoff showed that once people know the outcome, they think it was always predictable, without realizing their view has changed. Looking back from a CRISPR clinic, the path to salt-marsh microbes seems obvious. But it wasn’t.
Another habit is more subtle: we confuse money with expertise. Building a company is hard work, but it is not the same as making discoveries. Being successful in business does not mean someone is an expert in science. Funders often think they know more about discovery than they do, and scientists hold back when they should speak up.
We also contribute to this problem. Every grant proposal that promises a cure in five years teaches funders to expect quick results. If we want space for research that has no clear product yet, we need to stop pretending it is all applied research.
History shows that patience pays off. A study in the Proceedings of the National Academy of Sciences looked at the 210 new drugs the FDA approved from 2010 to 2016. NIH funding “contributed to every one,” mostly through basic research on biological targets. The public funded the science, and the products came later. Economists Andrew Fieldhouse and Karel Mertens estimate that social returns on nondefense public research are between 140 and 210 percent, with a best guess of 171 percent. Few private investments can match that.
The rest of the plan for this New Golden Age of Science worries me more. Its first goal is to “prioritize the individual scientist over legacy institutions.” Universities are those institutions. They are also the places where a 20-year question can be explored, where the person who answers it is trained, and where the costs are covered if the answer comes late. Jason Owen-Smith, a sociologist at the University of Michigan, put it simply: “Instead of working with a few hundred institutions, you’re now figuring out how to work with thousands.”
Some of the costs are already clear. This year, 55 top research universities admitted 15 percent fewer doctoral students, and international applications dropped by 21 percent. Those students would have spent the 2030s working on questions we can’t even imagine yet.
Partnerships can work, and often do. Donald Stokes called the productive middle ground use-inspired basic research. Pasteur worked in this space, and the White House report supports the idea. The best partnerships have one thing in common: scientists stay in charge of the questions.
So here is what I ask. To my colleagues: keep speaking up as professors. Explain what we know and what we don’t, and say “we don’t know yet” without feeling sorry. That uncertainty isn’t a weakness in our pitch. It’s actually the main point.
To our funders in government and industry: the discoveries your future products will need are being made now, in labs that can’t yet say what they’re for. A portfolio based only on conviction isn’t really a portfolio. Please keep supporting research that doesn’t have a clear goal yet, and judge its value over decades, not just a few months.
We can’t know which seeds will grow. All we can do is plant as many as possible.
Read Science: A New Golden Age Listen to the Interesting Times episode
Previous post
Giovanna Yumi Scorsim Omura Defends Her Dissertation